The complementary effects of an anticholinergic and sympathicomimetic drug inhalation in patients with severe chronic obstructive lung disease
- PMID: 138353
The complementary effects of an anticholinergic and sympathicomimetic drug inhalation in patients with severe chronic obstructive lung disease
Similar articles
-
[Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].Acta Tuberc Pneumol Belg. 1974 Sep-Oct;65(5):534-9. Acta Tuberc Pneumol Belg. 1974. PMID: 4282820 Clinical Trial. French. No abstract available.
-
[Combined treatment with ipratropin and fenoterol in chronic obstructive lung disease].Tidsskr Nor Laegeforen. 1982 Mar 30;102(9-10):558-9. Tidsskr Nor Laegeforen. 1982. PMID: 6218649 Norwegian. No abstract available.
-
[Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].Arch Monaldi. 1983 Sep-Dec;38(5-6):241-54. Arch Monaldi. 1983. PMID: 6238579 Clinical Trial. Italian. No abstract available.
-
New concepts in bronchodilator therapy.Am Fam Physician. 1986 Jan;33(1):218-29. Am Fam Physician. 1986. PMID: 2934965 Review. No abstract available.
-
Anticholinergic bronchodilators in obstructive airway disease.J Assoc Acad Minor Phys. 1991;2(3):118-22. J Assoc Acad Minor Phys. 1991. PMID: 1839720 Review.
Cited by
-
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma.Drugs. 1978 Jan;15(1):3-32. doi: 10.2165/00003495-197815010-00002. Drugs. 1978. PMID: 342228 Review.
-
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.Drugs. 1980 Oct;20(4):237-66. doi: 10.2165/00003495-198020040-00001. Drugs. 1980. PMID: 6448137 Review.